Table 4.
Identification of druggable targets.
| Gene | Target name | Drug name | Indication/associated conditions | |
|---|---|---|---|---|
| P2RY14 | P2Y Purinoceptor 14 | Investigational | MRS2690 | Discovery agent |
| In clinical trials | MC-1 | Coronary artery disease | ||
| Approved, investigational | Promethazine | Allergic conditions, nausea and vomiting, and motion sickness | ||
|
| ||||
| ATRAID | Apoptosis-related Protein 3 | Druggable | NA | NA |